Beijing Avistone Biotechnology Co Ltd has gained approval from the Chinese National Medical Products Administration to extend the application of vebreltinib for treating adult patients
Hyundai Bioscience made headlines on April th with its breakthrough announcement regarding the development of an oral anticancer drug targeting patients with intractable cancers
Apollomics Inc has announced a significant development regarding vebreltinib in China The National Medical Products Administration has granted approval to Avistone Biotechnology Co Ltd
Biolojic Design a biotech company specializing in AIdriven antibody innovation announced that Nektar has exercised its license option to develop a program resulting from their collaborative research started in
Amneal Pharmaceuticals Inc has unveiled its Over the Counter Naloxone Hydrochloride Nasal Spray USP mg after securing Abbreviated New Drug Application approval from the US Food and Drug Administration
Junshi Biosciences a leading biopharmaceutical company dedicated to innovative therapies has announced the acceptance of its New Drug Application by the Drug Office of the Hong Kong Special Administrative Region This NDA relates to toripalimab proposed for use in combination
PRISM BioLab Co Ltd a leading discovery and development biotechnology company designing small molecule inhibitors of proteinprotein interaction targets today announced that it has entered into a targetexclusive research and licensing agreement with ONO PHARMACEUTICAL CO LTD
Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that its selective cathepsin K inhibitor MIV has been granted
Our customers depend on the high performance and reliability of the plates used in their highthroughput processes However increased throughput results in a higher carbon footprint
Alkermes plc today announced initiation of the Vibrance study a phase clinical trial evaluating the safety and efficacy of ALKS compared to placebo in patients with narcolepsy type ALKS is the companys novel
Atom Bioscience a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases has begun enrolling patients
Cullinan Therapeutics Inc a biopharmaceutical company focused on modalityagnostic targeted therapies today announced that clinical data from its Phase trial of CLN in patients with advanced solid tumors
Boston, MA, USA
Bergamo, Italy
Boston, MA, USA
Boston, MA, USA
Chicago, Illinois, USA
Arizona,USA
Boston, MA, USA
Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT)
Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT)
Assistant Professor, Pharmaceutical Chemistry department, St. John Institute of Pharmacy and Research
Associate Professor and Head of Pharmaceutical Chemistry department, St. John Institute of Pharmacy and Research
Indian Institute of Technology, Banaras Hindu University
Indian Institute of Technology, Banaras Hindu University
Indian Institute of Technology, Banaras Hindu University
Indian Institute of Technology, Banaras Hindu University
Senior Manager Global Scientific Affairs
Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Renaud also serves on several standardisation and pharmacopoeia committees as well as on industry task forcesMNPs are classified into four types such as paramagnetic ferromagnetism antiferromagnetism ferrimagnetism these were differentiated depends on their several magnetic iron forming states at the time of crystallisation process Shows in fig Randomly aligned of magnetic motion of the ironcrystals with zero magnetisation demonstrates paramagnetism types
AbstractMany anticancer drugs have an impaired bioavailability and poor brain penetration because they are substrates to drug efflux pumps such as Pglycoprotein and Breast Cancer Resistance Protein Elacridar is a strong inhibitor of these two drug efflux pumps and therefore has great potential to improve oral absorption and brain penetration of many anticanc
AbstractPurposeTo compare the effects of nine months of exercise training and ibuprofen supplementation given immediately after exercise sessions on bone and muscle in postmenopausal womenMethodsIn a doubleblin
The University of Manchester has introduced an breakthrough in gene therapy targeting young children diagnosed with Hunter syndrome a rare and devastating lysosomal storage disorder
In an era of increasing regulatory demands the pharmaceutical industry faces the challenge of adhering to the Identification of Medicinal Products IDMP standards This whitepaper provides guidance to understanding and implementing IDMP compliance outlining the benefits and potential challenges and offering practical solutions We at AdEx Partners as Trusted Leaders in Business Transformation off...
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster